en
svPress releases
Regulatory press release 2023-12-01
Xspray Pharma raises SEK 92.3 million through warrants TO5
Press release 2023-11-21
Xspray Pharma’s XS003 Achieves Superior Bioavailability Milestone, Matching TASIGNA® at Reduced Dosage
Press release 2023-11-16
Important information to holders of warrants series TO5: The subscription period is ongoing
Regulatory press release 2023-11-09
Xspray Pharma’s large shareholders and key individuals declare their intent to exercise TO5 warrants in November
Regulatory press release 2023-11-08
Interim Report Third Quarter 2023
-
Latest report
Interim Report Q3 2023 -
Subscribe
Get our latest press releases and reports
